X0609 4 2026-05-14 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA 0002062834 Lippman Evan true C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 124 DVORA HANEVI'A ST., TEL AVIV ISRAEL L3 6944020 ISRAEL false true false false EVP, Business Development true Ordinary Shares 2026-05-14 4 M false 11841 A 11841 D Ordinary Shares 2026-05-14 4 S false 5746 35.5842 D 6095 D Ordinary Shares 2026-05-14 4 M false 74008 A 80103 D Ordinary Shares 2026-05-14 4 S false 35912 35.5842 D 44191 D Restricted Share Units 2026-05-14 4 M false 11841 0 D Ordinary Shares 11841 35524 D Restricted Share Units 2026-05-14 4 M false 74008 0 D Ordinary Shares 74008 74008 D The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.38 to $35.685, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Restricted share units were granted on May 14, 2025, with 11,841 vested on May 14, 2026, 11,841 vesting on each of May 14, 2027 and May 14, 2028, and 11,842 vesting on May 14, 2029. Restricted share units were granted on May 14, 2025, with 74,008 vested on May 14, 2026, and 37,004 vesting on each of May 14, 2027 and May 14, 2028. /s/ Dov Bergwerk as attorney-in-fact for Evan Lippman 2026-05-18